1-7 of 7
Angela Panoskaltsis-Mortari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

AnnaLynn M. Williams, Wei Liu, Matthew J. Ehrhardt, Sedigheh Mirzaei Salehabadi, Angela Panoskaltsis-Mortari, Nicholas S. Phillips, Daniel A. Mulrooney, Jamie E. Flerlage, Yutaka Yasui, Deokumar Srivastava, Leslie L. Robison, Melissa M. Hudson, Kirsten K. Ness, Noah D. Sabin, Kevin R. Krull
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1822–1832.
https://doi.org/10.1158/1078-0432.CCR-23-3709
Published: 01 May 2024
View article titled, Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma
Open the PDF for Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis-Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3440–3450.
https://doi.org/10.1158/1078-0432.CCR-15-2710
Published: 14 July 2016
View article titled, IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function
Open the PDF for IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function in another window
Includes: Supplementary data
Journal Articles

A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer

Brad J. Stish, Hua Chen, Yanqun Shu, Angela Panoskaltsis-Mortari, Daniel A. Vallera
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6486–6493.
https://doi.org/10.1158/1078-0432.CCR-07-0938
Published: 01 November 2007
View article titled, A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer
Open the PDF for A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer in another window
Journal Articles

Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv

Brad J. Stish, Hua Chen, Yanqun Shu, Angela Panoskaltsis-Mortari, Daniel A. Vallera
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3058–3067.
https://doi.org/10.1158/1078-0432.CCR-06-2454
Published: 15 May 2007
View article titled, Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv
Open the PDF for Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv in another window
Journal Articles

Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody

Daniel A. Vallera, Martin W. Brechbiel, Linda J. Burns, Angela Panoskaltsis-Mortari, Katie E. Dusenbery, Dennis R. Clohisy, Ellen S. Vitetta
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7920–7928.
https://doi.org/10.1158/1078-0432.CCR-05-0725
Published: 08 November 2005
View article titled, Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a <sup>90</sup>Y-Labeled Anti-CD22 Monoclonal Antibody
Open the PDF for Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a <sup>90</sup>Y-Labeled Anti-CD22 Monoclonal Antibody in another window
Journal Articles

Visualization of Immunotoxin-mediated Tumor Cell Death in Vivo

Heidi A. Erickson, Richard L. Reinhardt, John B. Hermanson, Angela Panoskaltsis-Mortari, Christopher A. Pennell
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 890s–894s.
Published: 01 March 2001
View article titled, Visualization of Immunotoxin-mediated Tumor Cell Death <em>in Vivo</em>
Open the PDF for Visualization of Immunotoxin-mediated Tumor Cell Death <em>in Vivo</em> in another window
Journal Articles

A Phase I Clinical, Pharmacological, and Biological Trial of Interleukin 6 Plus Granulocyte-Colony Stimulating Factor after Ifosfamide, Carboplatin, and Etoposide in Children with Recurrent/Refractory Solid Tumors: Enhanced Hematological Responses but a High Incidence of Grade III/IV Constitutional Toxicities

Francisco Bracho, Mark D. Krailo, Violet Shen, Sharon Bergeron, Virginia Davenport, Wen Liu-Mares, Bruce R. Blazar, Angela Panoskaltsis-Mortari, Carmella van de Ven, Rita Secola, Matthew M. Ames, Joel M. Reid, Gregory H. Reaman, Mitchell S. Cairo
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 58–67.
Published: 01 January 2001
View article titled, A Phase I Clinical, Pharmacological, and Biological Trial of Interleukin 6 Plus Granulocyte-Colony Stimulating Factor after Ifosfamide, Carboplatin, and Etoposide in Children with Recurrent/Refractory Solid Tumors: Enhanced Hematological Responses but a High Incidence of Grade III/IV Constitutional Toxicities
Open the PDF for A Phase I Clinical, Pharmacological, and Biological Trial of Interleukin 6 Plus Granulocyte-Colony Stimulating Factor after Ifosfamide, Carboplatin, and Etoposide in Children with Recurrent/Refractory Solid Tumors: Enhanced Hematological Responses but a High Incidence of Grade III/IV Constitutional Toxicities in another window